TTRX (Turn Therapeutics Inc. Common Stock) Stock Analysis - Community

Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of May 21, 2026, TTRX trades at $4.48 with a market cap of $145.96M and a P/E ratio of -40.28. TTRX moved +0.00% today. Year to date, TTRX is +0.63%; over the trailing twelve months it is flat. Its 52-week range spans $2.57 to $26.50. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade TTRX?

Rallies community data for TTRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

TTRX Key Metrics

Key financial metrics for TTRX
MetricValue
Price$4.48
Market Cap$145.96M
P/E Ratio-40.28
EPS$-0.12
Dividend Yield0.00%
52-Week High$26.50
52-Week Low$2.57
Volume6
Avg Volume0
Revenue (TTM)$0
Net Income$-3.19M
Gross Margin0.00%

Latest TTRX News

Recent TTRX Insider Trades

  • Chaudhary Zuraiz bought 2.50K (~$8.75K) on Dec 12, 2025.
  • GOLDEN ARTHUR F bought 9.87K (~$33.95K) on Nov 24, 2025.
  • GOLDEN ARTHUR F bought 20.53K (~$58.93K) on Nov 21, 2025.

TTRX Analyst Consensus

TTRX analyst coverage data. Average price target: $0.00.

Common questions about TTRX

How does the Rallies community trade TTRX?
Rallies community data for TTRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for TTRX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for TTRX when enough community data is available.
Is TTRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TTRX. It does not provide personalized investment advice.
TTRX

TTRX